Fierce Biotech News & Reports
WEBThe Fierce 50 of 2024. Shining a spotlight on the people and companies who are driving meaningful change in healthcare, pharma and biotech. Ayla Ellison Sep 9, 2024 5:00am. Medtech News.
MedTech | Fierce Biotech
WEBSep 5, 2024 · The tech giant plans to add sleep apnea detection to its Apple Watch and bring long-anticipated over-the-counter hearing aid tech to its AirPods. Conor Hale Sep 10, 2024 1:30pm. Connect. The Team ...
Biotech | Fierce Biotech
WEBFeb 12, 2024 · The companies will use Moderna’s mRNA-delivery nanoparticle platform to transport mRNA that codes for autoimmune targets directly into macrophages. Darren Incorvaia Sep 10, 2024 12:31pm. Connect.
New AI drug discovery powerhouse Xaira rises with $1B in funding
WEBApr 24, 2024 · The company emerged Tuesday with $1 billion in committed funding—that’s billion with a B—incubated by Arch Venture Partners and Foresite Labs with none other than Marc Tessier-Lavigne, Ph.D ...
CRO - Fierce Biotech
WEBDanish CRO Scantox buys genotoxicity specialist Gentronix. Gentronix will continue to operate under its current name while expanding its specialist regulatory toxicology services. Darren Incorvaia ...
Grail launches long-awaited Galleri blood test, its groundbreaking ...
WEBJun 7, 2021 · Grail took a major step forward in its quest to deliver a single blood test capable of detecting the presence of multiple cancers with the long-awaited launch of its Galleri diagnostic.
FDA clears first non-drug fibromyalgia treatment - Fierce Biotech
WEBMay 19, 2022 · FDA clears NeuroMetrix's wearable neuromodulator as first non-drug fibromyalgia treatment. Scientists still may not know the exact cause of fibromyalgia, but that hasn’t stopped them from ...
Grail delivers final study results showing its blood test's accuracy in ...
WEBJun 25, 2021 · The final results from a Grail study of its cancer-tracing blood test found it was accurate at detecting a range of different tumors at early stages—especially those more likely to be lethal and ha
A look at the R&D landscape in obesity, led by GLP-1s - Fierce …
WEBMar 19, 2024 · The obesity pipeline: Phase 2 assets. The baselines are already being set. Viking Therapeutics’ dual GLP-1 and GIP agonist produced weight loss of up to 14.7% after 13 weeks of treatment in data ...
Fierce Pharma Biopharma News & Insights - Fierce Biotech
WEBFeb 7, 2012 · Fierce 50 of 2024. Shining a spotlight on the people and companies who are driving meaningful change in healthcare, pharma and biotech. Ayla Ellison Sep 9, 2024 5:02am.